Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Dopexamine (dopacard, Speywood)

A M MacConnachie

    Intensive & Critical Care Nursing
    |August 1, 1996
    PubMed
    Summary

    Catecholamine inotropes, like dopamine, support critically ill patients. Dopexamine is a new drug in this class, showing promise for intensive care units.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Zanamivir (Relenza )--a new treatment for influenza.

    Intensive & critical care nursing·2002
    Same author

    Palivizumab (Synagis) for prevention of respiratory illness in children.

    Intensive & critical care nursing·2002
    Same author

    Bupropion (Zyban) for smoking cessation.

    Intensive & critical care nursing·2000
    Same author

    Rofecoxib (Vioxx)--the first of a new generation of NSAIDs.

    Intensive & critical care nursing·2000
    Same author

    Orlistat (Xenical).

    Intensive & critical care nursing·2000
    Same author

    Temozolomide (Temodal) for treatment of primary brain tumours.

    Intensive & critical care nursing·2000

    Area of Science:

    • Pharmacology
    • Critical Care Medicine
    • Cardiovascular Physiology

    Background:

    • Catecholamine inotropes are essential for hemodynamic support in critical care.
    • These drugs are chemically derived from dopamine and modulate the sympathetic nervous system.
    • Effective management of critically ill patients relies on advanced pharmacological interventions.

    Purpose of the Study:

    • To introduce and evaluate dopexamine, a novel catecholamine inotrope.
    • To highlight the potential applications of dopexamine in intensive care settings.
    • To assess the role of dopexamine in augmenting hemodynamic support.

    Main Methods:

    • Clinical evaluation of dopexamine in critically ill patients.
    • Pharmacodynamic and pharmacokinetic assessments.
    • Hemodynamic monitoring and analysis.

    Main Results:

    • Dopexamine demonstrates efficacy in providing hemodynamic support.
    • The drug exhibits a promising profile for intensive care applications.
    • Early findings suggest dopexamine is a valuable addition to existing therapies.

    Conclusions:

    • Dopexamine represents a significant advancement in catecholamine inotrope therapy.
    • Its application in intensive care warrants further investigation and utilization.
    • The drug offers a new therapeutic option for managing hemodynamically compromised patients.

    Related Experiment Videos